세계의 백신 전달 기기 시장 규모 : 디바이스별, 투여 경로별, 최종사용자별, 지역 범위별 및 예측

Vaccine Delivery Devices Market Size And Forecast

Vaccine Delivery Devices Market size was valued at USD 4.99 Billion in 2024 and is projected to reach USD 8.83 Billion by 2032, growing at a CAGR of 8.5% from 2026-2032.

• Vaccine delivery devices are tools and technologies specifically designed for the administration of vaccines. These devices are essential for healthcare professionals and individuals to ensure accurate dosage, safe delivery, and proper immunization against infectious diseases.
• Vaccine delivery devices are commonly used in healthcare facilities such as hospitals, clinics, and medical offices for routine immunization programs, including childhood vaccination schedules, seasonal flu vaccination campaigns, and other preventive healthcare initiatives.
• Vaccine delivery devices play a crucial role in community health programs and outreach efforts, particularly in rural or underserved areas where access to healthcare services may be limited.
• One of the latest vaccine delivery technologies, such as needle-free options, is effectively used in mass immunization programs. It helps to reduce the chances of needle stick injuries and the complications associated with the multiple uses of a single needle.
• Moreover, other vaccine delivery devices include jet injectors, disposable syringes, microneedles, and intradermal delivery devices. These are all used for the delivery of inactivated poliovirus vaccines.

Global Vaccine Delivery Devices Market Dynamics

The key market dynamics that are shaping the Vaccine Delivery Devices Market include:

Key Market Drivers:

• Robust Research and Development: The global increase in product supply is facilitating market expansion for vaccination programs aimed at eradicating endemic diseases. Governments, hospitals, and pharmaceutical corporations are promoting routine and affordable vaccinations, with active government surveillance ensuring everyone receives them at minimal cost.
• Expanded Immunization Coverage in Healthcare Sector: The demand for vaccine delivery devices is driven by efforts to expand immunization coverage and reach underserved populations, with collaboration between governments, healthcare organizations, and NGOs aiming to improve vaccination rates in low- and middle-income countries.
• Rising Healthcare Expenditure by Government: The demand for vaccine delivery devices is fueled by government-led initiatives to enhance immunization coverage and reach underserved populations, facilitated by collaborations between healthcare organizations and NGOs.
• Technological Advancements: The demand for needle-free delivery is surging due to the risks of needle stick injuries, infection from contaminated needles, and blood-borne infections from improperly sterilized needles. The market growth is expected to be driven by interest from key players, international organizations, and institutions in novel delivery technologies.
• For instance, in January 2022, Pfizer Inc. and Acuitas Therapeutics joined forces to develop a lipid nanoparticle delivery system that is specifically designed for mRNA vaccines and therapeutics. This collaboration aims to leverage the expertise of both companies to enhance the delivery efficiency and effectiveness of mRNA-based treatments and vaccines.

Key Challenges:

• High Costs of Vaccine Dose: The growing incidence of chronic and infectious diseases is driving market growth. However, high costs associated with the per-dose vaccine volume are hampering market expansion. Though international organizations are supplying millions of volume doses around the globe, many parts are yet to receive vaccination due to their high cost.
• Infrastructure Challenges: The supply chain of vaccines requires strict temperature control to maintain their potency. In regions with inadequate cold chain infrastructure, such as rural or remote areas, this becomes challenging, potentially compromising vaccine effectiveness and decreasing demand for vaccine delivery devices.
• Healthcare Workforce Capacity Challenges: A shortage of trained healthcare workers is hindering the proper administration of vaccines, leading to delays, dosage errors, and improper handling of delivery devices, affecting overall immunization outcomes, even with adequate delivery devices available.
• Disruptions in the Vaccine Supply Chain: Supply chain disruption such as manufacturing delays, distribution bottlenecks, and logistics challenges, is likely to impact the availability and accessibility of vaccine delivery devices. Supply chain disruptions, whether due to natural disasters, geopolitical tensions, or public health emergencies, may disrupt immunization programs and limit the deployment of vaccine delivery devices.

Key Trends:

• Painless Administration: There is growing interest in developing painless vaccine delivery methods to enhance patient comfort and acceptance. Technologies such as microneedle patches, which deliver vaccines through painless, minimally invasive skin punctures, offer potential advantages over traditional needle-based injections, particularly for pediatric and geriatric populations.
• Smart Injection Devices: Integration of digital health technologies into vaccine delivery devices, such as smart injection devices equipped with sensors and connectivity features, allows for real-time monitoring of vaccination administration, dosage tracking, and adherence to vaccination schedules. These devices facilitate data collection, enhance patient engagement, and support remote patient monitoring.
• Biodegradable and Eco-Friendly Materials: Increasing emphasis on sustainability and environmental responsibility drives the adoption of biodegradable and eco-friendly materials in vaccine delivery devices. Manufacturers are exploring alternatives to conventional plastics, such as bioplastics and compostable materials, to reduce environmental impact and promote circular economy principles.

Global Vaccine Delivery Devices Market Regional Analysis

Here is a more detailed regional analysis of the global Vaccine Delivery Devices Market:

North America:

• North America has established regulatory frameworks for healthcare products, including vaccine delivery devices, overseen by agencies like the FDA and Health Canada. These standards ensure safety, efficacy, and quality, boosting consumer confidence and market growth.
• The region is at the forefront of technological innovation in healthcare, including vaccine delivery devices. Advancements such as needle-free injectors, auto-disable syringes, and smart injection devices improve vaccine administration, enhance patient comfort, and optimize immunization outcomes.
• North America is home to several key market players, including pharmaceutical companies, medical device manufacturers, and healthcare technology firms. These companies drive innovation, research, and development in vaccine delivery devices, introducing new products and technologies to the market.

Europe:

• Europe places a strong emphasis on healthcare quality and safety, driving the adoption of advanced healthcare technologies and best practices. Vaccine delivery devices must meet high standards of safety, reliability, and performance to ensure patient well-being and public health outcomes.
• European governments provide support for vaccination programs through funding, policy development, and public health campaigns. National vaccination schedules, recommendations, and incentives encourage vaccination uptake and drive demand for vaccine delivery devices across healthcare settings.
• European countries continue to invest in healthcare infrastructure, research and development, and innovation to improve healthcare delivery and patient outcomes. Investments in vaccination programs, including the procurement of vaccine delivery devices, contribute to market growth and innovation in the region.

Asia Pacific:

• Asia Pacific is home to some of the world's most populous countries, including China and India. The sheer size of the population creates a substantial demand for vaccines and vaccine delivery devices to address healthcare needs.
• Economic growth in many countries across the Asia Pacific region has led to increased healthcare spending. Governments and private sectors are investing more in healthcare infrastructure, including vaccination programs and the procurement of vaccine delivery devices.
• There is a growing awareness among individuals and communities in the Asia Pacific about the importance of preventive healthcare measures, including vaccination. Public health campaigns, educational initiatives, and advocacy efforts contribute to increased vaccination uptake and demand for vaccine-delivery devices.
• Emerging economies in Asia Pacific, such as China, India, Indonesia, and Vietnam, offer significant growth opportunities due to their large populations and increasing investments in healthcare infrastructure. These countries are witnessing rapid urbanization, economic development, and healthcare reforms, driving demand for healthcare products and services, including vaccine delivery devices.

Global Vaccine Delivery Devices Market: Segmentation Analysis

The Global Medical Sensors Market is Segmented on the basis of Devices, Route Of Administration, End-User, And Geography.

Vaccine Delivery Devices Market, By Devices

• Syringes
• Jet Injectors

Based on Devices, The market is segmented into Syringes and Jet Injectors. Among these, syringes are expected to dominate the market as they provide flexibility in administering various vaccinations, including liquid and lyophilized vaccines (which are freeze-dried and need to be reconstituted before use). Syringes can be used in various immunization situations. However, the jet injectors segment of the Vaccine Delivery Devices Market is expanding at the quickest rate.

Vaccine Delivery Devices Market, By Route Of Administration

• Intradermal Vaccination
• Intramuscular Vaccination
• Subcutaneous Vaccination

Based on Route Of Administration, The market is segmented into Intradermal, Intramuscular, and Subcutaneous. The largest market segment is intradermal, which enhances immunogenicity by interacting directly with skin-derived immune cells. Intramuscular, the most rapidly growing segment, is recommended for administering a wide range of vaccinations, booster shots, and routine immunizations to individuals of all ages due to its versatility.

Vaccine Delivery Devices Market, By End-User

• Hospitals & Clinics
• Home Care Settings
• Ambulatory Surgery Centers

Based on End-User, The market is segmented into Hospitals & clinics, Home Care Settings, and Ambulatory Surgery Centers. Hospitals typically account for the majority share in the end-user segment of the Vaccine Delivery Devices Market. Hospitals often serve as centralized hubs for vaccination services, providing a wide range of vaccines to patients across various age groups and medical conditions. Academic medical centers and research hospitals play a key role in vaccine research, clinical trials, and medical education. They utilize vaccine delivery devices for research purposes, vaccine trials, and training healthcare professionals.

Key Players

The "Global Vaccine Delivery Devices Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are 3M, Becton Dickinson & Company, Gerresheimer AG, Bioject Medical Technologies, Inc. (Inovio Pharmaceutical Inc.), SCHOTT AG, Valeritas, PharmaJet, Vaxxas, and Corium International, Inc.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis.

• Vaccine Delivery Devices Market, Recent Developments
• In March 2022, The National Institute of Allergy and Infectious Diseases (NIAID) initiated a clinical trial to evaluate three experimental HIV vaccines. These vaccines are developed using a messenger RNA (mRNA) platform, which has been previously used in multiple Covid-19 vaccines that have been approved.
• In April 2023, the FDA approved CSL's immunoglobulin pre-filled syringe, Hizentra, for use in treating patients with chronic inflammatory demyelinating conditions. Primary Immunodeficiency (PI) and Polyneuropathy (CIDP). The injection offers convenient drug delivery and is ready for use.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL VACCINE DELIVERY DEVICES MARKET

• 1.1 Introduction of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL VACCINE DELIVERY DEVICES MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL VACCINE DELIVERY DEVICES MARKET, BY DEVICES

• 5.1 Overview
• 5.2 Syringes
• 5.3 Jet Injectors

6 GLOBAL VACCINE DELIVERY DEVICES MARKET, BY ROUTE OF ADMINISTRATION

• 6.1 Overview
• 6.2 Intradermal Vaccination
• 6.3 Intramuscular Vaccination
• 6.4 Subcutaneous Vaccination

7 GLOBAL VACCINE DELIVERY DEVICES MARKET, BY END-USER

• 7.1 Overview
• 7.2 Hospitals & Clinics
• 7.3 Home Care Settings
• 7.4 Ambulatory Surgery Centers

8 GLOBAL VACCINE DELIVERY DEVICES MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 U.K.
  • 8.3.3 France
  • 8.3.4 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Rest of the World
  • 8.5.1 Latin America
  • 8.5.2 Middle East and Africa

9 GLOBAL VACCINE DELIVERY DEVICES MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Ranking
• 9.3 Key Development Strategies

10 COMPANY PROFILES

• 10.1 3M
  • 10.1.1 Overview
  • 10.1.2 Financial Performance
  • 10.1.3 Product Outlook
  • 10.1.4 Key Developments
• 10.2 Becton Dickinson & Company
  • 10.2.1 Overview
  • 10.2.2 Financial Performance
  • 10.2.3 Product Outlook
  • 10.2.4 Key Developments
• 10.3 Gerresheimer AG
  • 10.3.1 Overview
  • 10.3.2 Financial Performance
  • 10.3.3 Product Outlook
  • 10.3.4 Key Developments
• 10.4 Bioject Medical Technologies, Inc. (Inovio Pharmaceutical Inc.)
  • 10.4.1 Overview
  • 10.4.2 Financial Performance
  • 10.4.3 Product Outlook
  • 10.4.4 Key Developments
• 10.5 SCHOTT AG
  • 10.5.1 Overview
  • 10.5.2 Financial Performance
  • 10.5.3 Product Outlook
  • 10.5.4 Key Developments
• 10.6 Valeritas
  • 10.6.1 Overview
  • 10.6.2 Financial Performance
  • 10.6.3 Product Outlook
  • 10.6.4 Key Developments
• 10.7 PharmaJet
  • 10.7.1 Overview
  • 10.7.2 Financial Performance
  • 10.7.3 Product Outlook
  • 10.7.4 Key Developments
• 10.8 Vaxxas
  • 10.8.1 Overview
  • 10.8.2 Financial Performance
  • 10.8.3 Product Outlook
  • 10.8.4 Key Developments
• 10.9 Corium International, Inc
  • 10.9.1 Overview
  • 10.9.2 Financial Performance
  • 10.9.3 Product Outlook
  • 10.9.4 Key Developments

11 Appendix

• 11.1 Related Research